SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
International Journal of Heart Failure · 2023 · 5 (2) · 82
DOI: 10.36628/ijhf.2022.0030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Heart Failure, 2023. Verfasst von Khawaja M Talha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA. Die Arbeit wurde bisher 186-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Abbott Vascular and Vifor International.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
- Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin,…
- Baylor Scott and White Research Institute, Dallas, TX, USA.
ORCID-Profile: Khawaja M Talha, Stefan D Anker, Javed Butler
Förderung
- Abbott Vascular and Vifor International
Zitieren
APA
Talha, K. M., Anker, S. D., & Butler, J. (2023). SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. International Journal of Heart Failure, 5(2), 82. https://doi.org/10.36628/ijhf.2022.0030
Vancouver
Talha KM, Anker SD, Butler J. SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence. International Journal of Heart Failure. 2023;5(2):82. doi:10.36628/ijhf.2022.0030
BibTeX
@article{Talha2023,
author = {Talha, Khawaja M and Anker, Stefan D and Butler, Javed},
title = {SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence},
journal = {International Journal of Heart Failure},
year = {2023},
volume = {5},
number = {2},
pages = {82},
doi = {10.36628/ijhf.2022.0030}
}
EUVIMED